What is new in Spatial Biology?
October 7th, Bergen
For more information and registration
We are delighted to invite you to the upcoming CCBIO Junior Scientist Symposium on October 3, 2024. This seminar series offers a fantastic opportunity to connect and engage with fellow young scientists. We look forward to vibrant and insightful discussions, as always.
We are honored to have Randi Hovland, the leader of the Cancer Genomics unit at Haukeland University Hospital, as our keynote speaker. She will share how her department utilizes advanced technology for molecular cancer diagnostics. Additionally, Hanan Ashrafi and Pouda Panahandeh will present their research on how IFN-gamma and the IRX3 Homeobox protein effect sensitivity to estrogen receptor (ER) inhibition. Lucrezia Berton from the Mohn Cancer Research Laboratory will discuss genetic features that predict neoadjuvant treatment outcomes in breast cancer. Lastly, Lorena Larios Salazar will present how nanodiamonds may enhance oral cancer treatment.
We hope to see you there for an enriching and inspiring experience! Please register within September 30th at 11.00.
When: October 3, 2024, at 09.15-13.00
Where: Møterom, HBE, Glasblokkene, Blokk 8, U1etg, U364, Auditorium, campus Haukeland, Bergen
Registration: on this link
Open to both junior and senior researchers as well as students. The symposium series is open, but also part of the CCBIO Research School under the code CCBIO901.
Program:
09.15-09.30: Introduction
09.30-10.15: “Introduction to genetic diagnostics of cancer” Keynote lecture by Randi Hovland
10.15-10.25: Coffee break
10.25-10.50: “IFN-gamma modulates NAD metabolism in breast cancer cells and enhances sensitivity to estrogen receptor antagonists” by Hanan Ashrafi
10.50-11.15: “Genetic features predicting effect of neoadjuvant breast cancer treatment” by Lucrezia Berton
11.15-12:00 Lunch (free of charge, register within September 30th at 11.00)
12:00-12:25: “Novel double functionalized nanodiamonds for targeted treatment to prevent oral cancer recurrence” by Lorena Larios Salazar
12:25-12:50: “The role of IRX3 Homeobox protein in estrogen receptor positive breast cancer and response to endocrine therapy” by Pouda Panahandeh
12:50-13:00: Concluding remarks
Mari Kyllesø Halle and Vladan Milosevic are coordinators of the junior seminars and are planning and chairing these meetings. Any questions can be addressed to them.
Read more about the CCBIO Junior Scientist Symposia here.
Welcome!
The support provided through the AURORA mobility programme should contribute to establishing and expanding contact between research organisations in Norway and corresponding organisations in France. The purpose is to strengthen European research collaboration under Horizon Europe.
Researchers from Norway may seek funding for short-term visits in France for the purpose of launching and developing new joint research projects.
The Plastic Network at UiB and collaborators will also this autumn organize a one-day symposium on microplastics, this time concerning Microplastics and Human Health.
During this meeting, we will focus on the multifaceted issues surrounding microplastic pollution, human exposure, and its impact on human health.
Title: Microplastics and Human Health; sources, exposure, and impact
Date: November 22nd , 2024
Location: Department of Biological Sciences, University of Bergen
Virtual access: Online attendance on Zoom is possible
Speakers: We have invited renowned experts and early career scientists in the field of microplastic research. Confirmed speakers so far include Dorthe Herzke (FHI), Asbjørn Jokstad (UiT), Øyvind Pernell Haugen (STAMI), and Damaris Daniel (UiB). Updated and detailed scientific program will be published online in due time.
Who should attend: This symposium is designed for researchers, healthcare professionals, environmental scientists, policy makers, and anyone interested in understanding the growing concern over microplastics and their implications for human health.
More information about the meeting including full scientific program and registration will be provided soon.
Warm regards,
Organizing committee: Amy Lusher (NIVA), Tanja Kögel (HI), Jutta Dierkes (UiB) and Odd André Karlsen (UiB)
The webinar will answer and discuss with the participants the following questions and issues:
The course language is English, and the course is delivered by Europa Media.
Barcelona, 22-25 October.
This four-day course offers a unique opportunity to delve into the complexities of translating biomedical discoveries into solutions for unmet medical needs. It explores the importance of a truly interdisciplinary approach, where collaboration across various disciplines is not just encouraged but essential.
https://eatris.eu/events/translational-medicine-explained-tmex-2024/
Monday October 7th in Stockholm
Bonnier Healthcare, together with Nordic Cancer Union’s members, invites you to the Nordic Cancer Conference. The venue will take place in Stockholm, Bonnier Huset, Torsgatan 21. It is also possible to participate by streaming.
The program is under construction and will be updated. It is designed together with a reference group consisting of:
Norwegian Cancer Society, Ole Alexander Opdalshei – Deputy Secretary General
The Swedish Cancer Society, Ulrica Sundholm, Manager Knowledge & Support
The Danish Cancer Society: Heidi Smollerup Rasmussen, Chief Consultant policy and legal
Bonnier Healthcare Norway, Martin Gray – Editor in Chief Dagens Medisin, and moderator for the conference.
We are delighted to welcome you to our conference where leading experts, researchers, and policymakers from across the Nordic countries come together to address one of the most pressing health challenges of our time: cancer. We will focus on four key areas: prevention, cancer strategy, access to new medicines, clinical trials.
https://www.dagensmedisin.no/dmarena/nordic-cancer-conference/641490
In 2024, the Trond Mohn Research Foundation (TMF) celebrates its 20th anniversary, marking two decades of significant contributions to research in Bergen and beyond. This milestone coincides with the co-location of researchers from three prominent Mohn Research Centers on the 7th floor of the University of Bergen’s BBB research building, where the new Bergen Center for Medical Stem Cell Research is being established.
To explore opportunities for collaboration between these three research centers, which all have common interests in neuroscience, stem cells, and cell biology, we are excited to organize the first Mohn Synergy Symposium on Thursday, August 29. Here, we will delve into common research interests and supplemental methodological approaches while honoring TMF’s contribution to scientific initiatives and progress.
The event is open to all, and no registration is required. Welcome!
Link to event: Mohn Synergy Symposium 2024 – Helse Bergen HF (helse-bergen.no)
More about the three Mohn Research Centres:
This conference will be arranged in Bergen at Alrek Health Cluster, 4th-25th October 2024.
You can find more Information here:Nasjonal forskningskonferanse i medisinsk og helsefaglig pedagogikk | Enhet for læring | UiB
Registration deadline: 27th September 2024.
In this webinar, you will get a short introduction to the FAIR-principles, and how and where you can archive your research data. The webinar is planned for 20.09.2024 at 10.15–11.00.
You can read more here: How and where can you archive your research data? | University of Bergen Library | UiB
The goal of the University of Bergen is that data resulting from research activity should be made readily available for reuse in accordance with FAIR-principles. Researchers are encouraged to make their data openly available as early as possible in the research process
Sharing and re-using quality-assured research data is considered good scientific practice. Most funders, e.g. Norwegian Research Council or Horizon Europe, and publishers require that the research data from a project is made openly available. The saying is «as open as possible, as restricted as necessary», meaning that research data should be openly available unless prevented by legitimate considerations relating to security, protection of personal privacy, IPR or trade secrets.